Buy Arimidex (Anastrozole) Online – Beligas USA
Arimidex® (Anastrozole) by Beligas USA is a powerful non-steroidal aromatase inhibitor (AI) commonly used in post cycle therapy (PCT) and estrogen management protocols. It works by blocking the aromatase enzyme, which prevents the conversion of testosterone into estrogen—helping maintain hormonal balance during and after anabolic cycles.
Originally developed for the treatment of hormone-receptor-positive breast cancer, Arimidex has become widely recognized in performance and bodybuilding communities for its effectiveness in controlling estrogen-related side effects.
Product Overview
| Feature | Details |
|---|---|
| Active Ingredient | Anastrozole |
| Classification | Non-steroidal Aromatase Inhibitor |
| Half-Life | ~48 hours |
| Dosage | 0.5–1 mg per day |
| Aromatization | No |
| Water Retention | No |
| Hepatotoxicity | No |
| Manufacturer | Beligas Pharmaceuticals (USA) |
| Warehouse | USA Warehouse |
| Pack Size | 50 tablets × 1 mg |
What Is Arimidex Used For?
Medical Use
Arimidex is clinically approved for:
-
Treatment of estrogen-dependent breast cancer
-
Long-term estrogen suppression under medical supervision
Bodybuilding & PCT Use
In performance enhancement settings, Arimidex is commonly used to:
-
Prevent gynecomastia
-
Reduce estrogen-related water retention
-
Support a dry, lean, and defined physique
-
Maintain testosterone effectiveness during cycles
Arimidex does not suppress testosterone production—it only reduces estrogen levels.
Key Benefits of Arimidex (Anastrozole)
-
Effectively blocks estrogen conversion
-
Helps prevent gynecomastia
-
Reduces bloating and edema
-
Improves muscle hardness and definition
-
Suitable for use during cycles or post-cycle therapy
Dosage & Administration
-
Typical dose: 0.5–1 mg per day
-
Onset of full effect: 10–14 days of consistent use
-
Tablets are taken orally with water
⚠️ Estrogen levels should not be suppressed excessively. Always follow a structured protocol.
Safety & Warnings
-
For adult use only
-
Keep out of reach of children
-
Not intended for women who are pregnant or breastfeeding
-
Long-term use should be medically supervised
Consult a healthcare professional before use, especially if you have a history of hormonal or cardiovascular conditions.
Trusted Medical References
-
FDA – Anastrozole Drug Information
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020541s026lbl.pdf -
NHS – Aromatase Inhibitors Overview: https://www.nhs.uk/medicines/anastrozole/
-
PubMed – Anastrozole Mechanism of Action: https://pubmed.ncbi.nlm.nih.gov/
-
Explore Post Cycle Therapy Products
Reviews
There are no reviews yet.